L. Alic, M. Van-vliet, and J. Veenland, Regional heterogeneity changes in DCE-MRI as response to isolated limb perfusion in experimental soft-tissue sarcomas, Contrast Media & Molecular Imaging, vol.50, issue.11, pp.340-349, 2013.
DOI : 10.1088/0031-9155/50/11/L01

D. Andreou, M. Werner, and D. Pink, Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma, British Journal of Cancer, vol.11, issue.3, pp.455-60, 2015.
DOI : 10.1002/1097-0142(19880901)62:5<994::AID-CNCR2820620526>3.0.CO;2-4

S. Bahri, J. Chen, and H. Yu, Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer?, Annals of Oncology, vol.19, issue.4, pp.822-826, 2008.
DOI : 10.1093/annonc/mdn043

R. Benjamin, H. Choi, and C. Charnsangavej, We Should Desist Using RECIST, at Least in GIST, Journal of Clinical Oncology, vol.25, issue.13, pp.1760-1764, 2007.
DOI : 10.1200/JCO.2006.07.3411

M. Benz, M. Allen-auerbach, and W. Weber, Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas, Journal of Nuclear Medicine, vol.49, issue.10, pp.1579-1584, 2008.
DOI : 10.2967/jnumed.108.053694

M. Benz, J. Czernin, and M. Alen-auerbach, FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas, Clinical Cancer Research, vol.15, issue.8, pp.2856-2863, 2009.
DOI : 10.1158/1078-0432.CCR-08-2537

R. Canter, S. Martinez, and D. Borys, Radiographic and Histologic Response to Neoadjuvant Radiotherapy in Patients With Soft Tissue Sarcoma, Annals of Surgical Oncology, vol.76, issue.Suppl 2, pp.2578-84, 2010.
DOI : 10.1016/j.ijrobp.2009.03.015

H. Choi, C. Charnsangavej, and R. Benjamin, Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria, Journal of Clinical Oncology, vol.25, issue.13, pp.1753-1762, 2007.
DOI : 10.1200/JCO.2006.07.3049

J. Coindre, B. Nguyen, and A. De-mascarel, Modifications histologiques après chimiothérapie des sarcomes des tissus mous de l'adulte [Histological changes after chemotherapy of soft tissue sarcomas in the adult], Ann Pathol, vol.5, issue.2, pp.95-104, 1985.

S. Cousin, A. Crombé, and A. Italiano, Clinical, radiological and genetic features, associated with the histopathologic response to neoadjuvant chemotherapy (NAC) and outcomes in locally advanced soft tissue sarcoma (STS) patients (STS), Journal of Clinical Oncology, vol.35, pp.15-11014, 2017.

D. Grande, F. Subhawong, T. Fayad, and L. , Detection of Soft-Tissue Sarcoma Recurrence: Added Value of Functional MR Imaging Techniques at 3.0 T, Radiology, vol.271, issue.2, pp.499-511, 2014.
DOI : 10.1148/radiol.13130844

A. Dingemans, A. De-langen, and H. Groen, First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging, Annals of Oncology, vol.22, issue.3, pp.559-66, 2011.
DOI : 10.1093/annonc/mdq391

J. Dyke, D. Panicek, and D. Ballon, Osteogenic and Ewing Sarcomas: Estimation of Necrotic Fraction during Induction Chemotherapy with Dynamic Contrast-enhanced MR Imaging, Radiology, vol.228, issue.1, pp.271-279, 2003.
DOI : 10.1148/radiol.2281011651

M. Egmont-petersen, P. Hogendoorn, and J. Reiber, Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing???s sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling, Magnetic Resonance Imaging, vol.18, issue.5, pp.525-560, 2000.
DOI : 10.1016/S0730-725X(00)00144-2

E. Eisenhauer, P. Therasse, and J. Verweij, New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), European Journal of Cancer, vol.45, issue.2, pp.228-275, 2009.
DOI : 10.1016/j.ejca.2008.10.026

W. Enneking, S. Spanier, and M. Malawer, The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh, Cancer, vol.84, issue.5, pp.1005-1027, 1981.
DOI : 10.1148/110.3.541

V. Evilevitch, W. Weber, and W. Tap, Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas, Clinical Cancer Research, vol.14, issue.3, pp.715-720, 2008.
DOI : 10.1158/1078-0432.CCR-07-1762

M. Fiore, F. Grosso, and A. Gronchi, Myxoid/round cell and pleomorphic liposarcomas, Cancer, vol.103, issue.12, pp.2522-2553, 2007.
DOI : 10.1200/JCO.2005.04.160

URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.22720/pdf

F. Biomarker and W. Group, BEST (Biomarkers, EndpointS, and other Tools) resource. NCBI http, 2016.

R. Gillies, P. Kinahan, and H. Hricak, Radiomics: Images Are More than Pictures, They Are Data, Radiology, vol.278, issue.2, pp.563-77, 2016.
DOI : 10.1148/radiol.2015151169

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734157/pdf

L. Gimber, E. Montgomery, and L. Fayad, MRI characteristics associated with high-grade myxoid liposarcoma, Clinical Radiology, vol.72, issue.7, pp.613-614, 2017.
DOI : 10.1016/j.crad.2017.01.016

A. Gronchi, S. Ferrari, and P. Casali, Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial, The Lancet Oncology, vol.18, issue.6, pp.812-822, 2017.
DOI : 10.1016/S1470-2045(17)30334-0

F. Grosso, R. Jones, and P. Casali, Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study, The Lancet Oncology, vol.8, issue.7, pp.595-602, 2007.
DOI : 10.1016/S1470-2045(07)70175-4

L. Guillou, J. Coindre, and J. Costa, Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma., Journal of Clinical Oncology, vol.15, issue.1, pp.350-62, 1997.
DOI : 10.1200/JCO.1997.15.1.350

O. Hahn, C. Yang, and W. Stadler, Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacodynamic Biomarker Study of Sorafenib in Metastatic Renal Carcinoma, Journal of Clinical Oncology, vol.26, issue.28, pp.4572-4580, 2008.
DOI : 10.1200/JCO.2007.15.5655

J. Haniball, V. Sumathi, and R. Grimer, Prognostic Factors and Metastatic Patterns in Primary Myxoid/Round-Cell Liposarcoma, Sarcoma, vol.14, issue.5, p.538085, 2011.
DOI : 10.1155/2007/36785

URL : https://doi.org/10.1155/2011/538085

S. Hanna, B. Fletcher, D. Parham, and M. Bugg, Muscle edema in musculoskeletal tumors: MR imaging characteristics and clinical significance, Journal of Magnetic Resonance Imaging, vol.23, issue.4, pp.441-450, 1991.
DOI : 10.2214/ajr.151.2.231

S. Hanna, D. Parham, and B. Fletcher, Assessment of Osteosarcoma Response to Preoperative Chemotherapy Using Dynamic FLASH Gadolinium-DTPA-Enhanced Magnetic Resonance Mapping, Investigative Radiology, vol.27, issue.5, pp.367-73, 1992.
DOI : 10.1097/00004424-199205000-00010

K. Herrmann, M. Benz, and J. Czernin, 18F-FDG-PET/CT Imaging as an Early Survival Predictor in Patients with Primary High-Grade Soft Tissue Sarcomas Undergoing Neoadjuvant Therapy, Clinical Cancer Research, vol.18, issue.7, pp.2024-2031, 2012.
DOI : 10.1158/1078-0432.CCR-11-2139

URL : http://clincancerres.aacrjournals.org/content/clincanres/18/7/2024.full.pdf

A. Hollebecque, A. Adenis, and N. Penel, Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients, Investigational New Drugs, vol.13, issue.suppl 2, pp.529-559, 2010.
DOI : 10.1007/s10637-009-9262-4

W. Huang, B. Beckett, and C. Ryan, Evaluation of Soft Tissue Sarcoma Response to Preoperative Chemoradiotherapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Tomography, vol.2, issue.4, pp.308-316, 2016.

R. Issels, L. Lindner, and P. Hohenberger, Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study, The Lancet Oncology, vol.11, issue.6, pp.561-70, 2010.
DOI : 10.1016/S1470-2045(10)70071-1

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517819/pdf

A. Jackson, O. Connor, J. Parker, G. Jayson, and G. , Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Clinical Cancer Research, vol.13, issue.12, pp.3449-59, 2007.
DOI : 10.1158/1078-0432.CCR-07-0238

URL : http://clincancerres.aacrjournals.org/content/clincanres/13/12/3449.full.pdf

W. Jarnagin, L. Schwartz, and N. Kemeny, Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival, Annals of Oncology, vol.20, issue.9
DOI : 10.1093/annonc/mdp029

L. Grange, F. Cassoni, A. Seddon, and B. , Tumour volume changes following pre-operative radiotherapy in borderline resectable limb and trunk soft tissue sarcoma, European Journal of Surgical Oncology (EJSO), vol.40, issue.4, pp.394-401, 2014.
DOI : 10.1016/j.ejso.2014.01.011

E. Kluza, E. Rozeboom, and R. Beets-tan, T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer, European Radiology, vol.21, issue.1, pp.253-61, 2013.
DOI : 10.1007/s00330-011-2220-5

V. Kumar, Y. Gu, and R. Gillies, Radiomics: the process and the challenges, Magnetic Resonance Imaging, vol.30, issue.9, pp.1234-1282, 2012.
DOI : 10.1016/j.mri.2012.06.010

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563280/pdf

P. Lambin, E. Rios-velazquez, and H. Aerts, Radiomics: Extracting more information from medical images using advanced feature analysis, European Journal of Cancer, vol.48, issue.4, pp.441-447, 2012.
DOI : 10.1016/j.ejca.2011.11.036

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533986/pdf

J. Landis and G. Koch, The Measurement of Observer Agreement for Categorical Data, Biometrics, vol.33, issue.1, pp.159-74, 1977.
DOI : 10.2307/2529310

C. Lavini, Simulating the effect of input errors on the accuracy of Tofts??? pharmacokinetic model parameters, Magnetic Resonance Imaging, vol.33, issue.2, pp.222-257, 2015.
DOI : 10.1016/j.mri.2014.10.004

M. Leach, B. Morgan, and A. Padhani, Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging, European Radiology, vol.37, issue.7, pp.1451-64, 2012.
DOI : 10.1007/s00259-010-1448-7

E. Limkin, R. Sun, and C. Ferté, Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology, Annals of Oncology, vol.28, issue.6, pp.1191-1206, 2017.
DOI : 10.1093/annonc/mdx034

URL : https://hal.archives-ouvertes.fr/hal-01648559

G. Liu, H. Rugo, and R. Herbst, Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Pharmacodynamic Measure of Response After Acute Dosing of AG-013736, an Oral Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors: Results From a Phase I Study, Journal of Clinical Oncology, vol.23, issue.24, pp.5464-73, 2005.
DOI : 10.1200/JCO.2005.04.143

D. Lucas, M. Kshirsagar, and S. Schuetze, Histologic Alterations from Neoadjuvant Chemotherapy in High-Grade Extremity Soft Tissue Sarcoma: Clinicopathological Correlation, The Oncologist, vol.13, issue.4, pp.451-459, 2008.
DOI : 10.1634/theoncologist.2007-0220

URL : http://theoncologist.alphamedpress.org/content/13/4/451.full.pdf

J. Meyer, K. Perlewitz, and C. Ryan, Phase I Trial of Preoperative Chemoradiation plus Sorafenib for High-Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates, Clinical Cancer Research, vol.19, issue.24, pp.6902-6913, 2013.
DOI : 10.1158/1078-0432.CCR-13-1594

C. Messiou, S. Bonvalot, and R. Haas, Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer ??? Soft Tissue and Bone Sarcoma Group (EORTC ??? STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging, European Journal of Cancer, vol.56, pp.37-44, 2016.
DOI : 10.1016/j.ejca.2015.12.008

W. Monsky, J. B. Chaudhari, and A. , Semi-automated volumetric quantification of tumor necrosis in soft tissue sarcoma using contrast-enhanced MRI, Anticancer Res, vol.32, issue.11, pp.4951-61, 2012.

B. Morgan, A. Thomas, and W. Steward, Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, in Patients With Advanced Colorectal Cancer and Liver Metastases: Results From Two Phase I Studies, Journal of Clinical Oncology, vol.21, issue.21, pp.3955-64, 2003.
DOI : 10.1200/JCO.2003.08.092

K. Mouridsen, S. Christensen, L. Gyldensted, and L. Ostergaard, Automatic selection of arterial input function using cluster analysis, Magnetic Resonance in Medicine, vol.52, issue.3, pp.524-555, 2006.
DOI : 10.1016/S0140-6736(86)90837-8

A. Padhani and K. Miles, Multiparametric Imaging of Tumor Response to Therapy, Radiology, vol.256, issue.2, pp.348-64, 2010.
DOI : 10.1148/radiol.10091760

S. Partovi, V. Tengg-kobligk, H. Robbin, and M. , Advanced Noncontrast MR Imaging in Musculoskeletal Radiology, Radiologic Clinics of North America, vol.53, issue.3, pp.549-67, 2015.
DOI : 10.1016/j.rcl.2015.01.005

S. Pasquali, E. Palassini, and A. Gronchi, Neoadjuvant treatment, Current Opinion in Oncology, vol.29, issue.4, pp.253-259, 2017.
DOI : 10.1097/CCO.0000000000000372

N. Perkins and E. Schisterman, The Inconsistency of ???Optimal??? Cutpoints Obtained using Two Criteria based on the Receiver Operating Characteristic Curve, American Journal of Epidemiology, vol.163, issue.7, pp.670-675, 2006.
DOI : 10.1093/aje/kwj063

W. Reddick, R. Bhargava, and B. Fletcher, Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy, Journal of Magnetic Resonance Imaging, vol.4, issue.6, pp.689-94, 1995.
DOI : 10.1148/radiology.184.1.1319075

P. Reichardt, T. Lindner, and B. Dörken, Chemotherapy in alveolar soft part sarcomas, European Journal of Cancer, vol.39, issue.11, pp.1511-1517, 2003.
DOI : 10.1016/S0959-8049(03)00264-8

T. Rukat, S. Walker-samuel, and S. Reinsberg, Dynamic contrast-enhanced MRI in mice: An investigation of model parameter uncertainties, Magnetic Resonance in Medicine, vol.24, issue.5, pp.1979-87, 2015.
DOI : 10.1002/nbm.1648

M. Salzer-kuntschik, G. Delling, G. Beron, and S. R. , Morphological grades of regression in osteosarcoma after polychemotherapy ? Study COSS 80, Journal of Cancer Research and Clinical Oncology, vol.106, issue.S1, pp.21-25, 1983.
DOI : 10.1007/BF00625047

M. Saponara, S. Stacchiotti, P. Casali, and A. Gronchi, (Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair, European Journal of Cancer, vol.70, pp.1-11, 2017.
DOI : 10.1016/j.ejca.2016.09.030

R. Sanfilippo and P. Casali, The intriguing patterns of tumor response to trabectedin, Expert Review of Anticancer Therapy, vol.13, issue.sup1, pp.21-25, 2013.
DOI : 10.1634/theoncologist.13-S2-4

T. Soldatos, S. Ahlawat, and L. Fayad, Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences, Radiology, vol.278, issue.3, pp.831-871, 2016.
DOI : 10.1148/radiol.2015142463

S. Stacchiotti, P. Collini, and P. Casali, High-Grade Soft-Tissue Sarcomas: Tumor Response Assessment???Pilot Study to Assess the Correlation between Radiologic and Pathologic Response by Using RECIST and Choi Criteria, Radiology, vol.251, issue.2, pp.447-56, 2009.
DOI : 10.1148/radiol.2512081403

S. Stacchiotti, P. Verderio, and A. Gronchi, Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy, Cancer, vol.113, issue.18S, pp.5857-66, 2012.
DOI : 10.1002/cncr.23592

D. Sullivan, Metrology Standards for Quantitative Imaging Biomarkers, Radiology, vol.277, issue.3, pp.813-825, 2015.
DOI : 10.1148/radiol.2015142202

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666097/pdf

P. Tofts, G. Brix, and R. Weisskoff, Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: Standardized quantities and symbols, Journal of Magnetic Resonance Imaging, vol.10, issue.3, pp.223-255, 1999.
DOI : 10.1002/(SICI)1522-2586(199909)10:3<221::AID-JMRI1>3.0.CO;2-X

M. Trojani, G. Contesso, and C. Lagarde, Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system, International Journal of Cancer, vol.2, issue.1, pp.37-42, 1984.
DOI : 10.1002/ijc.2910330108

M. Uhl, U. Saueressig, and M. Langer, Osteosarcoma, Investigative Radiology, vol.41, issue.8, pp.618-641, 2006.
DOI : 10.1097/01.rli.0000225398.17315.68

C. Van-rijswijk, M. Geirnaerdt, and J. Bloem, Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results, European Radiology, vol.13, issue.8, pp.1849-58, 2003.
DOI : 10.1007/s00330-002-1785-4

C. Van-rijswijk, M. Geirnaerdt, and J. Bloem, Soft-Tissue Tumors: Value of Static and Dynamic Gadopentetate Dimeglumine???enhanced MR Imaging in Prediction of Malignancy, Radiology, vol.233, issue.2, pp.493-502, 2004.
DOI : 10.1148/radiol.2332031110

B. Viglianti, M. Lora-michiels, and M. Dewhirst, Dynamic Contrast-enhanced Magnetic Resonance Imaging as a Predictor of Clinical Outcome in Canine Spontaneous Soft Tissue Sarcomas Treated with Thermoradiotherapy, Clinical Cancer Research, vol.15, issue.15, pp.4993-5001, 2009.
DOI : 10.1158/1078-0432.CCR-08-2222

E. Wardelmann, R. Haas, and S. Bonvalot, Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer???Soft Tissue and Bone Sarcoma Group (EORTC???STBSG) recommendations for pathological examination and reporting, European Journal of Cancer, vol.53, pp.84-95, 2016.
DOI : 10.1016/j.ejca.2015.09.021

L. White, J. Wunder, and R. Kandel, Histologic assessment of peritumoral edema in soft tissue sarcoma, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.5
DOI : 10.1016/j.ijrobp.2004.08.036

X. Zhang, Y. Chen, E. Fakhri, and G. , Synergistic role of simultaneous PET/MRI-MRS in soft tissue sarcoma metabolism imaging, Magnetic Resonance Imaging, vol.34, issue.3, pp.276-285, 2016.
DOI : 10.1016/j.mri.2015.10.027